These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32603203)

  • 21. Formulation and Optimization of Topical Solid Lipid Nanoparticles based Gel of Dapsone Using Design of Experiment.
    Deshkar SS; Bhalerao SG; Jadhav MS; Shirolkar SV
    Pharm Nanotechnol; 2018; 6(4):264-275. PubMed ID: 30394227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of a Thermosensitive In Situ Gel Containing Mometasone Furoate on a Rat Allergic Rhinitis Model.
    Altuntaş E; Yener G; Doğan R; Aksoy F; Şerif Aydın M; Karataş E
    Am J Rhinol Allergy; 2018 May; 32(3):132-138. PubMed ID: 29644886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigator-masked comparison of tazarotene gel q.d. plus mometasone furoate cream q.d. vs. mometasone furoate cream b.i.d. in the treatment of plaque psoriasis.
    Koo JY; Martin D
    Int J Dermatol; 2001 Mar; 40(3):210-2. PubMed ID: 11422529
    [No Abstract]   [Full Text] [Related]  

  • 24. Transethosomes of Econazole Nitrate for Transdermal Delivery: Development, In-vitro Characterization, and Ex-vivo Assessment.
    Verma S; Utreja P
    Pharm Nanotechnol; 2018; 6(3):171-179. PubMed ID: 30101725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative potency of formulations of mometasone furoate in terms of inhibition of 'PIRHR' in the forearm skin of normal human subjects measured with laser doppler velocimetry.
    Kulhalli P; Chevli T; Karnik R; Sheth M; Mulgaonkar N
    Indian J Dermatol Venereol Leprol; 2005; 71(3):170-4. PubMed ID: 16394405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality by Design Assisted Development of Luliconazole Transethosomes in Gel for the Management of
    Singh G; Narang RK
    Assay Drug Dev Technol; 2024 Jan; 22(1):1-17. PubMed ID: 38156818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioequivalence of 0.1% mometasone furoate lotion to 0.1% mometasone furoate hydrogel.
    Greive KA; Barnes TM
    Australas J Dermatol; 2016 May; 57(2):e39-45. PubMed ID: 25545549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decrease in enkephalin levels in psoriatic lesions after calcipotriol and mometasone furoate treatment.
    Nissen JB; Avrach WW; Hansen ES; Stengaard-Pedersen K; Kragballe K
    Dermatology; 1999; 198(1):11-7. PubMed ID: 10026395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy study of vesicular gel containing methotrexate and menthol combination on parakeratotic rat skin model.
    Nagle A; Goyal AK; Kesarla R; Murthy RR
    J Liposome Res; 2011 Jun; 21(2):134-40. PubMed ID: 20557280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formulation and evaluation of the topical ethosomal gel of melatonin to prevent UV radiation.
    Shukla R; Tiwari G; Tiwari R; Rai AK
    J Cosmet Dermatol; 2020 Aug; 19(8):2093-2104. PubMed ID: 31829513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methotrexate Aspasomes Against Rheumatoid Arthritis: Optimized Hydrogel Loaded Liposomal Formulation with In Vivo Evaluation in Wistar Rats.
    Ghosh S; Mukherjee B; Chaudhuri S; Roy T; Mukherjee A; Sengupta S
    AAPS PharmSciTech; 2018 Apr; 19(3):1320-1336. PubMed ID: 29340978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of Topical Nanoemulgel Using Combined Therapy for Treating Psoriasis.
    Bhardwaj S; Gaur PK; Tiwari A
    Assay Drug Dev Technol; 2022 Jan; 20(1):42-54. PubMed ID: 34883035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation.
    El-Ridy MS; Yehia SA; Mohsen AM; El-Awdan SA; Darwish AB
    Curr Drug Deliv; 2018; 15(1):122-133. PubMed ID: 28240177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low drug load, high retention mometasone furoate cream with polyglyceryl - 3 oleate as a chemical enhancer: Formulation development, in vivo and in vitro evaluation and molecular mechanisms.
    Jia W; Pang Y; Zhao C; Cai Y; Zhang Y; Liu C; Fang L
    Int J Pharm; 2024 Jun; 659():124284. PubMed ID: 38810934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formulation and evaluation of a topical liposomal gel containing a combination of zedoary turmeric oil and tretinoin for psoriasis activity.
    Chen J; Ma Y; Tao Y; Zhao X; Xiong Y; Chen Z; Tian Y
    J Liposome Res; 2021 Jun; 31(2):130-144. PubMed ID: 32223352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanostructured lipid carriers for the topical delivery of tretinoin.
    Ghate VM; Lewis SA; Prabhu P; Dubey A; Patel N
    Eur J Pharm Biopharm; 2016 Nov; 108():253-261. PubMed ID: 27519827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of Topical Gel of Methotrexate Incorporated Ethosomes and Salicylic Acid for the Treatment of Psoriasis.
    Chandra A; Aggarwal G; Manchanda S; Narula A
    Pharm Nanotechnol; 2019; 7(5):362-374. PubMed ID: 31490769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Transethosomal Gel Containing Miconazole Nitrate; Development, Characterization, and Enhanced Antifungal Activity.
    Asghar Z; Jamshaid T; Sajid-Ur-Rehman M; Jamshaid U; Gad HA
    Pharmaceutics; 2023 Oct; 15(11):. PubMed ID: 38004517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New Vehiculation Systems of Mometasone Furoate for the Treatment of Inflammatory Skin Diseases.
    Taléns-Visconti R; Perra M; Ruiz-Saurí A; Nácher A
    Pharmaceutics; 2022 Nov; 14(12):. PubMed ID: 36559053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diversifying the skin cancer-fighting worthwhile frontiers: How relevant are the itraconazole/ascorbyl palmitate nanovectors?
    Lamie C; Elmowafy E; Attia DA; Elmazar MM; Mortada ND
    Nanomedicine; 2022 Jul; 43():102561. PubMed ID: 35417773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.